Aurinia Pharmaceuticals Inc (AUPH) Stock Is Emerging from the Clouds

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

Investing in Aurinia Pharmaceuticals Inc (AUPH) Stock: Methodology

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

Oppenheimer Sets Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Stock to “a Perform”

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

Offering unique exposure at competitive prices: Aurinia Pharmaceuticals Inc (AUPH) Stock

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Stock Price Advanced 1.05% to $5.78

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

Aurinia Pharmaceuticals Inc (AUPH) Stock Is Looking Attractive

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. We previously noted in another research note published on May 05, 2022 by Cantor Fitzgerald that resumed the stock to an Overweight with a price target […]

There Is Nothing Like Aurinia Pharmaceuticals Inc (AUPH) Stock

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]

Aurinia Pharmaceuticals Inc (AUPH) Stock creates opportunities due to its volume and complexity

Oppenheimer raised the price target for the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) stock from “an Outperform” to “a Perform”. The rating was released on November 04, 2022, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report […]